Session Details
[29P]ADME, PK/PD ,Drug interaction/Controlled release · Targeting/Drug delivery system in therapy/Others
Sat. Mar 29, 2025 8:30 AM - 3:00 PM JST
Sat. Mar 29, 2025 11:30 PM - 6:00 AM UTC
Sat. Mar 29, 2025 11:30 PM - 6:00 AM UTC
Poster (MARINE MESSE FUKUOKA Hall B: Exhibition Room [1F])
[29PA-218S]Develop a microdialysis coupled with a UHPLC system for the pharmacokinetics and placenta transfer of the anti-monkeypox drug cidofovir in rats
○Pei-Hsuan Lee1, Deng-Jye Yang1, Tung-Hu Tsai2 (1. Institute of Food Safety and Health Risk Assessment, National Yang Ming Chiao Tung University, Taipei 112, Taiwan, 2. Institute of Traditional Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei 112, Taiwan)
[29PB-219S]Microdialysis coupled with UHPLC-MS/MS for biotransformation and pharmacokinetics of oseltamivir in rat blood and brain
○Ping-Chia Huang1, Tung-Hu Tsai 1 (1. Institute of Traditional Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan)
[29PA-220]On the Pharmacokinetic Drug-Drug Interactions of Nemonoxacin in Rats
Ruei-Lin Wu1, Wei-Chun Wang1, Ching-Ling Cheng2, ○CHEN-HSI CHOU1 (1. Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, 2. School of Pharmacy, College of Medicine, Tzu Chi University)
[29PB-221S]Effect of IVIG in combination with antibiotics on a mouse model of infectious sepsis
○Ruka Kamimoto1, Mitsuaki Yoshimura1, Yuka Nagatsuka 1, Yuhki Sato1 (1. Fac. Pharm. Pharmaceut. Sci, Fukuyama Univ.)
[29PA-222S]Effect of febuxostat on human organic anion transporter 3-mediated transport of methotrexate
○Sakura Kobayashi1, Kenji Ikemura2,3, Danni Wang3, Masahiro Okuda2,3 (1. Sch. Pharm. Sci., Osaka Univ., 2. Dept. Pharm., Osaka Univ. Hosp., 3. Grad. Sch. Med., Osaka Univ.)
[29PB-223]Application of a new formulation technology for OTC combination drugs containing ibuprofen and acetaminophen: Improving pharmacokinetics of the components
○Shiho Yamane1, Ichiro Kawase1, Valentine Polivka2, Clemence Rauch2, Nobuo Miyadai1, Naoki Uchida3 (1. SSP Co.,Ltd., 2. Opella, a Sanofi company, Neuilly-sur-Seine, France, 3. Showa University Karasuyama Hospital)
[29PA-224S]Comparison of inhibitory potency of OATP1B1 inhibitors among genetic variants
○Tomoko Hirano1, Kazunari Tsujii2, Manami Tanino1, Ayuko Imaoka1,2,3, Takeshi Akiyoshi1,2,3, Hisakazu Ohtani1,2,3,4 (1. Fac. Pharm. Sci., Keio Univ., 2. Grad. Sch. Pharm. Sci., Keio Univ., 3. Sch. Med., Keio Univ., 4. Dept. Pharm., Keio Univ. Hosp.)
[29PB-225]Characterization of Lurasidone Drug-Drug Interactions in Rats Using a Novel CYP3A Probe Mosapride
Wei-Chun Wang2, Kuang-Yu Hsieh2, Chen-Hsi Chou2, ○CHING-LING CHENG1 (1. School of Pharmacy, Tzu Chi University, 2. Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University)
[29PA-226S]Inhibition kinetics of grapefruit juice components on CYP3A5 activity
○Yu Sakamoto1, Kana Koinuma2, Ayuko Imaoka1,3, Katsunori Nakamura4, Hiroshi Yamazaki5, Takeshi Akiyoshi1,3, Hisakazu Ohtani1,3,6 (1. Fac. Pharm., Keio Univ., 2. Grad. Sch. Pharm. Sci., Keio Univ., 3. Sch. Med., Keio Univ., 4. Dept. Pharm., Ryukyu Univ. Hosp., 5. Sch. Pharm., Showa Pharmaceutical Univ., 6. Dept. Pharm., Keio Univ. Hosp.)
[29PB-227S]Effects of the SGLT2 inhibitor empagliflozin on plasma concentrations and urinary excretion of 1,5-anhydroglucitol and glucose in rats
○Yurika Yamazaki1, Hideyuki Motohashi1, Riki Furukawa1, Yumiko Takebayashi1, Junya Nagai1 (1. Osaka Med. Pharm. Univ.)
[29PA-228]Effects of creatinine on the plasma concentrations of metformin and cimetidine in rat
○yuichi ichimura1, rina sakamoto1, takuma nakata1, masako oda1, hiroshi saitoh1 (1. Health Sciences University of Hokkaido)
[29PB-229S]Establishment of a simple HPLC-FLD method for determination of ivermectin concentrations in plasma, tissues, and worms
○Asuka Taguchi1, Aina Ikezoe1, Khueangchiangkhwang Sukhonthip2, Midori Soda1, Yasuhisa Oida1, Tsuyoshi Yokoi1, Yoichi Maekawa2, Kiyoyuki Kitaichi1 (1. Gifu Pharm. Univ., 2. Department of Parasitology, Gifu Univ. Graduate School)
[29PA-230S]Omics-based exploration of molecular mechanisms in hepatotoxicant-induced mitochondrial dysfunction
○Ayaka Tsubokura1, Saki Kimura1, Kazuma Hamada1 (1. Fac. Pharm. Sci.,Teikyo Heisei Univ.)
[29PB-231S]Examination of conditions for the development of human blood-brain barrier model using microfluidic devices
○Ryuto Isogai1, Mei Fukuda1, Hanae Morio1, Ryo Kitamura2, Hiroshi Kimura3, Tomomi Furihata1 (1. Sch Pharm, Tokyo Univ Pharm & Life Sci., 2. TOKYO OHKA KOGYO CO.,LTD, 3. MNTC, Tokai Univ.)
[29PA-232S]Analysis of lipid metabolic pathways involved in mitochondrial permeability transition
○Saki Kimura1, Ayaka Tsubokura1, Kazuma Hamada1 (1. Fac. Pharm. Sci., Teikyo Heisei Univ.)
[29PB-233]Intranasal Administration of VEGFR Inhibitors for Efficient Drug Delivery to Cervical Lymph Nodes
○Tomoyuki Furubayashi1, Akiko Tanaka1, Minori Kobayashi1, Nao Hamada1, Toshiyasu Sakane1 (1. Kobe Pharmaceutical Univ.)
[29PA-234S]UVB-responsive liposomes containing γ-oryzanol
○Aika Kikuyama1, Yoko Niki2,3, Reiko Yoshida2, Ryoko Uda1 (1. National Institute of Technology, Nara College, 2. Mukogawa Women's University,Pharm. Sci., 3. Mukogawa Women's University, Research institute for Health Science)
[29PB-235S]Preparation of ionic liquids with choline/monoterpene anions and permeation of sulindac through rat skin.
○Haruka Nagahama1, Nanako Jogu1, Koki Takeda1, Asako Nishimura1, Nobuhito Shibata1 (1. Doshisha Women's College of Liberal Arts)
[29PA-236S]Human immortalized cell-based blood-brain barrier spheroid models offer a tool for the applicability assessment in characterizing the brain permeability of cyclic peptides
○Kana Yamamoto1, Seiya Ohki1, Hanae Morio1, Shingo Ito2, Sumio Ohtsuki2, Tomomi Furihata1 (1. Tokyo Univ Pharm & Life Sci., 2. Kumamoto Univ.)
[29PB-237]Engineered lipoprotein nanocarrier for lung-targeted drug delivery.
○Kasirawat SAWANGRAT1,3, Niphawan PANTI2, Tipanun BOUYAM1, Pawarun TOMANEEPITAK1, Pattaraporn PINTHONG1, Haruka KURITA3, Tsukasa OHASHI3, Tatsuya MURAKAMI3,4 (1. Department of Pharmaceutical Sciences, Faulty of Pharmacy, Chiang Mai University, Chiang Mai, 50200, Thailand, 2. Division of Biotechnology, Faculty of Agro-Industries, Chiang Mai, University, Chiang Mai, 50100, Thailand, 3. Department of Biotechnology and Pharmaceutical Engineering, Graduate School of Engineering, Toyama Prefectural University, 5180 Kurokawa, Imizu City, Toyama 939-0398, Japan, 4. Institute for Integrated Cell–Material Sciences (iCeMS), Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan)
[29PA-238S]Development of modified human serum albumin aimed at crossing the blood-brain barrier
○Keiju Ichikawa1, Yuki Kobayashi1, Yu Ishima1 (1. Kyoto Pharm. Univ.)
[29PB-239S]Development of lipid-coated α-mangostin (MGS)-encapsulated cyclodextrin nanoparticles for controlled release of MGS
○Madoka Toya1, Tomoki Kosugi2, Yukio Kitade1, Kazuo Sakurai2, Noriko Miyamoto1 (1. Dept. of Appl. Chem., AIT, 2. Grad. Prog. Env. Sys., The Univ. of Kitakyushu)
[29PA-240S]Design and evaluation of nanofiber composite tablets composed of chitosan/methacrylate copolymer S
○Michika Nakagawa1, Koki Takeda1, Asako Nishimura1, Nobuhito Sibata1 (1. Doshisha Women’s College of Liberal Arts)
[29PB-241S]Preparation and pharmaceutical evaluation of cyclophosphamide polymeric micelle formulations by poloxamer 407
○Momoko Sawada1, Koki Takeda1, Asako Nishimura1, Nobuhito Shibata1 (1. Doshisha Women's College of Liberal Arts)
[29PA-242S]Design of doxorubicin-loaded two-layered sheet formulation applied to tumor surface for selective chemotherapy
○Nao Mitsudome1, Fei Yuan1, Hirotaka Miyamoto1, Shintaro Fumoto1, Koyo Nishida1 (1. Grad. Sch. Biomed. Sci., Nagasaki Univ.)
[29PB-243]Tumor accumulation of boron agents using hyaluronic acid
○Rumi Yamaoki1, Ryo Ochiai1, Masahiko Hirata1 (1. Fac. Pharm., Osaka. Med. Pharm. Univ.)
[29PA-244S]Development of pH-responsive self-destructive liposome for efficient drug release in tumor microenvironment
○Sae Akaki1, Yusuke Kono1, Hiroyasu Takemoto2, Makoto Oba2, Masaki Morishita1, Ken-ichi Ogawara1 (1. Kobe Pharm Univ., 2. Grad. Sch. Med. Sci., Kyoto Pref Univ. Med.)
[29PB-245]Development of an intradermal delivery device applicable from large animals to mice and investigation of the administration route for mRNA-LNP formulations in mice.
○Shintaro Onishi1, Koki Sugimoto2, Atsuko Otsuka1, Yuta Suzuki1, Natsumi Koike1, Ryota Shiiba2, Takatoshi Niitsu2, Masaki Yamamoto1, Takehiko Tohjo2, Takuya Mori1 (1. Biological Science Research, Kao Corporation, 2. Processing Development Research, Kao Corporation)
[29PA-246S]Solubilization of carbamazepine in aqueous solutions of gemini-type surfactant micelles
○Sota Uchihara1, Rie Amamoto1, Runa Kifuji1, Ayana Kimura1, Hiromichi Nakahara1 (1. Daiichi Univ. Pharm.)
[29PB-247]Establishment of preparation and evaluation of ultrasound-responsive nanobubbles for an antibody delivery
○Yoichi Negishi1, Yusuke Yano1, Karin Yokota1, Mizuki Obara1, Taiki Yamaguchi1, Nobuhito Hamano1, Yamato Kikkawa1, Yoko Endo-Takahashi1 (1. Sch. Pharm., Tokyo Univ. of of Pharm. Life Sci.)
[29PA-248]Neutrophil targeting antibody-modified liposomes and microfluidic chip for evaluation of interaction properties
○Yoko Endo-Takahashi1, Misaki Tsujisawa1, Amane Osanai1, Satoshi Yotsumoto2, Ryo Ishihara3, Yamato Kikkawa1, Masato Tanaka2, Yoichi Negishi1 (1. Sch. Pharm., Tokyo Univ. Pharm. Life Sci., 2. Sch. Life Sci., Tokyo Univ. Pharm. Life Sci., 3. Fac. Med., Juntendo Univ.)
[29PB-249S]Design and evaluation of poly(N-isopropylacrylamide) hydrogel formulations encapsulating 5-fluorouracil
○Yui Isoda1, Koki Takeda1, Asako Nishimura1, Nobuhito Shibata1 (1. Doshisha Women's College of Liberal Arts)
[29PA-250]Formulation development for TAK-901 loaded liposome for tumor targeting
○Yutaka Nishimoto1, Kaoru Takenaka1, Tomomi Sato1 (1. Takeda Pharmaceutical Company Limited.)
[29PB-251]Enhanced Drug Skin Permeation by Azone-Mimic Ionic Liquids: Effects of Fatty Acids, a Constituent of Ionic Liquids
○Rika Kawakubo1, Takeshi Oshizaka1, Shunsuke Kodera1, Issei Takeuchi1, Kenji Mori1, Kenji Sugibayashi1 (1. Faculty of Pharm. Sci., Josai International Univ.)
[29PA-252]Sustained antifibrotic effects of pirfenidone encapsulated in succinylated gelatin-coated liposomes: In vitro studies with NRK-49F, WI-38, and RI-T fibroblasts
○Kohei Togami1,2, Yukimune Kanehira1, Yuki Nakamura1, Sumio Chono1,2 (1. Hokkaido University of Science, 2. Creation Research Institute of Life Science in KITA-no-DAICHI)
[29PB-253]Clerodendrum chinense stem extract and nanoparticles: Effects
on proliferation, apoptosis, cell cycle arrest, and mitochondrial membrane potential in breast cancer cells
○Chuda Chittasupho1, Weerasak Samee, Mingkwan Na Takuathung, Siriporn Okonogi , Sathaporn Nimkulrat, Sirivan Athikomkulchai (1. Faculty of Pharmacy, Chiang Mai University)
[29PA-254]Antibacterial activity of protein hydropersulfides
○Daito Kobayashi1, Shunsuke Miyai1, Yuki Kobayashi1, Yu Ishima1 (1. Kyoto Pharm. Univ.)
[29PB-255]Study on Enzyme Replacement Therapy for Chronic Granulomatous Disease
○Hideaki Nakamura1, Hiroyuki Nunoi2, Toyoki Nishimura2, Makoto Matsukura1, Yamato Uchida1, Momoka Yoshinaga1, Mamoru Haratake1 (1. Facul.Pharm.Sci., Sojo Univ., 2. Sch. Med., Miyazaki, Univ.)
[29PA-256S]The inhibitory effect of novel protein hydropersulfides on cancer cell proliferation
○Hina Ishiguro1, Daito Kobayashi1, Yuki Kobayashi1, Yu Ishima1 (1. Kyoto Pharm. Univ.)
[29PB-257S]Development of antibody fragment-polymer conjugates for type 1 diabetes treatment
○Keisuke Iida1,2, Makoto Matsui2, Kyohei Muguruma1,2, Yuto Honda1,2,3, Yutaka Miura1,2, Nobuhiro Nishiyama1,2,3 (1. Dept. of Life Sci. and Tech., Science Tokyo, 2. Lab. for Chem. and Life Sci., Science Tokyo, 3. iCONM)
[29PA-258S]Synthesis and Evaluation of Polymer-Conjugates of Angiotensin-Converting Enzyme Inhibitory Peptides
○Masaya Morimitsu1, Hideaki Nakamura1, Mamoru Haratake1 (1. Facul. Pharm. Sci. Sojo Univ)
[29PB-259S]Evaluation of immune-associated molecules on the surface of extracellular vesicles derived from calcitriol-treated dendritic cells.
○Mio Taneike1, Yuki Kobayashi1, Yu Ishima1 (1. Kyoto Pharm. Univ.)
[29PA-260]Combined use of bird-bill microneedle and iontophoresis for skin penetration of drugs
○Naoki Kishikawa1, Takahiro Oniki2, Masaya Hara2, Takahiro Ito1, Tomohiro Hikima1 (1. Graduate School of Computer Science and Systems Engineering., Kyusyu Institute of Technology, 2. Mishima Kosan Co., Ltd.)
[29PB-261S]Study on the physicochemical properties and anti-melanoma activity of Bakuchiol transethosomes
○PEI-YU HSIEH1, Chun-Yin Yang2, Shiuan Fu3, Chien-Ju Lin5,1, Feng-Lin Yen5,4 (1. School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, 2. Department of Pharmacy and Master Program, Collage of Pharmacy and Health Care, Tajen University, 3. Doctoral Degree Program in Toxicology, College of Pharmacy, Kaohsiung Medical University, 4. Department of Fragrance and Cosmetic Science, College of Pharmacy, Kaohsiung Medical University, 5. Department of Medical Research, Kaohsiung Medical University Hospital)
[29PA-262S]β-Carotene-loaded casein nanoparticles as a strategy to improve oral absorption and mitigate muscle atrophy
○Wan-Yi Liu1, Yu-Tse Wu1,2,3 (1. School of Pharmacy, Kaohsiung Medical University, 2. Center for Cancer Research, Kaohsiung Medical University, 3. Department of Medical Research, Kaohsiung Medical University Hospital)
[29PB-263S]CD8-positive cells act a crucial role in the anti-tumor effect of TNFalpha-expressing recombinant Bifidobacteria.
○Sae Araki1, Masakazu Kato1, Hiroki Ehara1, Rina Fukasawa1, Hiromi Saito1, Katsuhiro Isoda1, Ikuko Taira1, Yuichiro Taira1 (1. Facul. Pharm. Sci., Teikyo Heisei Univ.)
[29PA-264S]Application research to cancer therapy of lipid nanoparticle developed in Kyushu University
○Ryotaro Tsukamoto1, Noyuri Kudo1, Yuya Yoshida1, Makoto Yoritate1, Yurie Kikunaga1, Hidenori Teraoka1, Kengo Hamamura1, Kazuma Kiyotani2, Yusuke Nakamura2, Hirosato Kondo2, Shigehiro Ohdo1, Go Hirai1, Naoya Matsunaga1 (1. Grad. Sch. Pharm. Sci., Kyushu Univ., 2. NIBIOHN)
[29PB-265S]Preparation, physicochemical characterizations, in vitro skin penetration and antioxidant activity: Polydatin nanoparticles
○Wei-Ju Wu1, Hsuan Fu2, Feng-Lin Yen3 (1. Master Degree of Fragrance and Cosmetic Science, College of Pharmacy, Kaohsiung Medical University., 2. Doctoral Degree Program in Toxicology, College of Pharmacy, Kaohsiung Medical University., 3. Department of Fragrance and Cosmetic Science, College of Pharmacy, Kaohsiung Medical University)
[29PA-266S]Effect of aggregation state on activation of CD44 target-directed hyaluronic acid-modified glutathione-responsive prodrugs.
○Tomona Yukimura1, Tomohiro Seki1, Toshinobu Seki1 (1. Pharm., Josai Univ.)
[29PA-267S]Preparation of CD44-recognition peptide-modified nosylated doxorubicin and evaluation of its cellular uptake
○Yuna Goto1, Tomona Yukimura1, Tomohiro Seki1, Toshinobu Seki1 (1. Pharm., Josai Univ.)